Andrew Sinclair

Biopharm Services Ltd
Andrew Sinclair founded BioPharm Services in December 1998 to develop a technology based business focused on all aspects of the design and operation of biopharmaceuticals manufacturing. The company has developed software tools and databases for economic analysis and optimisation of bioprocesses and manufacturing operations. It also has developed unique insights into the market biomanufacturing market dynamics. Biopharm Services has 14 employees based both in the UK and the US. Sinclair has over 20 years experience within the biopharmaceutical sector working for manufacturing operations (Lonza, Eli Lilly, GlaxoSmithKline) and contractors (Kvaerner, Jacobs engineering).

Related Articles

Single-Use Technology Waste in Manufacturing Operations
Technical
Single-Use Technology Waste in Manufacturing Operations

Single-use products used in the production of biologics provide flexibility that was unimaginable a few years ago. The implementation of single-use technology (SUT) in manufacturing operations has accelerated due to reduced risk, flexible process equipment adjustments, and lower capital cost. The widespread use of this technology has raised questions about its impact on the environment due to...

Plastic Process Waste in Biopharmaceutical Manufacturing
Features
Plastic Process Waste in Biopharmaceutical Manufacturing

This article presents a comprehensive analysis of plastic waste generation in the biopharmaceutical industry, focusing on using single-use technologies (SUT) in bioprocessing for monoclonal antibody (mAb) production. It aims to inform sustainable practices within the biopharmaceutical industry and to encourage the development of more sustainable disposable technologies.